A tailored approach to BRAF and MLH1 methylation testing in a universal screening program for Lynch syndrome
Tomer Adar(Harvard University), Daniel C. Chung(Icahn School of Medicine at Mount Sinai), Anthony R. Mattia(Maine Medical Center), Kristen M. Shannon(Massachusetts General Hospital), Linda Rodgers(Massachusetts General Hospital), A. John Iafrate(Peter MacCallum Cancer Centre), Tianle Ma(Wind Power Engineering (Japan)), Makoto Yoshida(Harvard University), Gregory Y. Lauwers(University of South Florida)
Cited by 73
Related Papers
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
|Nature Biotechnology|2014|2.3k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Gastroenteropancreatic neuroendocrine tumours
|The Lancet Oncology|2008|1.8k
Detection of Mutations in <i>EGFR</i> in Circulating Lung-Cancer Cells
|New England Journal of Medicine|2008|1.6k